Literature DB >> 9495669

Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus.

T A Wichelhaus1, J Schulze, K P Hunfeld, V Schäfer, V Brade.   

Abstract

Four thousand eighty-eight Staphylococcus aureus isolates obtained from patients hospitalised in a university clinic and four community hospitals over a period of one year were screened for methicillin resistance. A resistance rate of 5% was detected among initial isolates. Distribution of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus showed an increased prevalence of MRSA in clinically significant specimens such as blood, central venous catheter tips, bronchial secretions, and wound secretions. Typing of 110 MRSA strains (initial isolates) by macrorestriction analysis of chromosomal DNA revealed 26 different genotypes that could be divided into five epidemic and 21 sporadic strains. More than 50% of all isolates belonged to one type that was confirmed to be closely related to the "southern-German" epidemic strain. Production of virulence factors such as enterotoxin A-D and toxic shock syndrome-toxin 1 among MRSA strains (initial isolates) occurred in ten of 26 different MRSA types. A strong correlation between genotype and toxin production was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9495669     DOI: 10.1007/BF01700555

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence.

Authors:  G L French; A F Cheng; J M Ling; P Mo; S Donnan
Journal:  J Hosp Infect       Date:  1990-02       Impact factor: 3.926

Review 2.  Diagnosis and management of methicillin resistant Staphylococcus aureus infection.

Authors:  G J Duckworth
Journal:  BMJ       Date:  1993-10-23

3.  Clonal dissemination of two MRSA strains in Germany.

Authors:  W Witte; C Cuny; C Braulke; D Heuck
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

4.  Production of "virulence factors" by "epidemic" methicillin-resistant Staphylococcus aureus in vitro.

Authors:  J Z Jordens; G J Duckworth; R J Williams
Journal:  J Med Microbiol       Date:  1989-12       Impact factor: 2.472

5.  Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus.

Authors:  J E Coia; L Browning; L Haines; T H Birkbeck; D J Platt
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

6.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

Review 7.  Molecular aspects of methicillin resistance in Staphylococcus aureus.

Authors:  H de Lencastre; B L de Jonge; P R Matthews; A Tomasz
Journal:  J Antimicrob Chemother       Date:  1994-01       Impact factor: 5.790

8.  Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia.

Authors:  E Lewis; L D Saravolatz
Journal:  Am J Infect Control       Date:  1985-06       Impact factor: 2.918

9.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

10.  [Epidemiological study of Staphylococcus aureus isolated from the Japanese National University and Medical College Hospitals with coagulase typing, and production of enterotoxins and toxic shock syndrome toxin-1].

Authors:  A Kimura; H Igarashi; H Ushioda; K Okuzumi; H Kobayashi; T Otsuka
Journal:  Kansenshogaku Zasshi       Date:  1992-11
View more
  8 in total

1.  Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; V Schäfer; V Brade; B Böddinghaus
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Authors:  Silke Besier; Albrecht Ludwig; Johannes Zander; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

3.  A STRATEGY FOR RAPID IDENTIFICATION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS NASAL CARRIER STATUS.

Authors:  P K Menon; A B Desai; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  COMPARISON OF RAPID METHOD OF DNA EXTRACTION USING MICROWAVE IRRADIATION WITH CONVENTIONAL PHENOL CHLOROFORM TECHNIQUE FOR USE IN MULTIPLEX PCR FOR mec A AND fem B GENES TO IDENTIFY GENOTYPES OF MRSA FROM CULTURES.

Authors:  P K Menon; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Biological cost of rifampin resistance from the perspective of Staphylococcus aureus.

Authors:  Thomas A Wichelhaus; Boris Böddinghaus; Silke Besier; Volker Schäfer; Volker Brade; Albrecht Ludwig
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Rapid detection of epidemic strains of methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; S Kern; V Schäfer; V Brade
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.

Authors:  Silke Besier; Johannes Zander; Ekkehard Siegel; Stephan H Saum; Klaus-Peter Hunfeld; Annabelle Ehrhart; Volker Brade; Thomas A Wichelhaus
Journal:  J Clin Microbiol       Date:  2008-10-01       Impact factor: 5.948

8.  The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.

Authors:  Silke Besier; Johannes Zander; Barbara C Kahl; Peter Kraiczy; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.